Preparation and biological evaluation of 166Ho-BPAMD as a potential therapeutic bone-seeking agent

Journal of Radioanalytical and Nuclear Chemistry

Volumn 304, Issue 3, 2015, Pages 1285-1291

  Yousefnia, Hassan ^a   Amraei, Naeimeh ^b   Hosntalab, Mohammad ^b   Zolghadri, Samaneh ^a   Bahrami Samani, Ali ^a  

^a NUCLEAR SCIENCE AND TECHNOLOGY RESEARCH INSTITUTE   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

166Ho; Biodistribution; Bone marrow ablation; BPAMD; Scintigraphy

Indexed keywords

HYDROXYAPATITE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; [4 [[[BIS(PHOSPHONOMETHYL)]CARBAMOYL]METHYL] 7,10 BIS(CARBOXYMETHYL) 1,4,7,10 TETRAAZACYCLODODEC 1 YL]ACETIC ACID HO 166;

ANIMAL EXPERIMENT; ARTICLE; BINDING ASSAY; BONE; CONTROLLED STUDY; DRUG PROTEIN BINDING; DRUG STABILITY; ISOTOPE LABELING; MOUSE; NONHUMAN; PARTITION COEFFICIENT; PH; QUALITY CONTROL; RADIOCHEMISTRY; TISSUE DISTRIBUTION;

EID: 84935012949     PISSN: 02365731     EISSN: 15882780     Source Type: Journal    
DOI: 10.1007/s10967-014-3924-1     Document Type: Article

References (17)

1. Child AH (2003) High dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med 348:1875
2. Alexanian R, Barlogie B (1990) New treatment strategies for multiple myeloma. Am J Hematol 35:194-198
3. Rostom AY, O'Cathail SM, Folkes A (1984) Systemic irradiation in multiple myeloma: a report on nineteen cases. Br J Haematol 58:423-431
4. Cavo M, Gobbi M, Tura S (1981) Peptichemio in multiple myeloma, (preliminary results). Haematologica 66:208-215
5. 166Ho-DOTMP plus melphalan followed by peripheral blood stem cell transplantation in patients with multiple myeloma: results of two phase I/II trials. Blood 102:2684-2691
6. Palma E, Correia JDG, Campello MPC, Santos I (2011) Bisphosphonates as radionuclide carriers for imaging or systemic therapy. Mol BioSyst 7:2950-2966
7. 68Ga-BPAMD: PET-imaging of bone metastases with a generator based positron emitter. Nucl Med Biol 39:993-999
8. 68Ga-bisphosphonates: first human study. Eur J Nucl Med Mol Imaging 37:834
9. Calhoun JM, Cessna JT, Coursey BM, Hoppes DD, Schima FJ, Unterweger MP (1992) Standardization of holmium-166 by the CIEMAT/NIST liquid scintillation efficiency-tracing method. Radioact Radiochem. 2:38-45
10. 166Ho-DOTMP radiation-absorbed dose estimation for skeletal targeted radiotherapy. J Nucl Med 47:534-542
11. 166Ho-TTHMP for human based on biodistribution data in rats. Appl Radiat Isot 94:260-265
12. 166Ho-EDTMP: a potential in vivo generator system for bone marrow ablation. Nucl Med Commun 25:615-621
13. Zeevaart JR, Jarvis NV, Louw WK, Jackson GE (2001) Metal-ion speciation in blood plasma incorporating the tetraphosphonate, N, N-dimethylenephosphonate-1-hydroxy-4-aminopropilydenediphosphonate (APDDMP), in therapeutic radiopharmaceuticals. J Inorg Biochem 83:57-65
14. 166Ho complexes with tetraazamacrocycles containing methylcarboxylate and/or methylphosphonate pendant arms. Radiochim Acta 95:335-341
15. IAEA-TECDOC-1340 (2003) Manual for reactor produced radioisotopes. ISBN 92-0-101103-2, ISSN 1011-4289, IAEA, Austria
16. 153Sm complexes: correlation with molecular modeling interaction studies. Nucl Med Biol 29:329-338
17. Du XL, Zhang TL, Yuan L, Zhao YY, Li RC, Wang K, Yan SC, Zhang L, Sun H, Qian ZM (2002) Complexation of ytterbium to human transferrin and its uptake by K562 cells. Eur J Biochem 269:6082-6090